TriTAC® Technology
Watch our TriTAC technology unleash the target cell-killing properties of a patient’s own immune system.
Science
Harpoon has created a novel antibody-based drug discovery platform called TriTAC®, which offers a new way to unleash the target cell-killing properties of a patient’s own immune system.
Careers
Harpoon is seeking energetic, passionate scientists and innovators to join our effort.
Recent News
January 13,
2021
Harpoon Therapeutics Granted Orphan Drug Designation from FDA for HPN217 for Treatment of Multiple Myeloma
January 11,
2021
Harpoon Therapeutics Announces Closing of Public Offering of Common Stock